Revision of Deep Brain Stimulator in Patients With Parkinson's Disease
Recruiting
N/A
Interventional Study
Pain Management
Regional Anesthesia
Deep Brain Stimulation
Parkinsons Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Ankara Etlik City Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Parkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control. It is associated with the loss of dopamine-producing cells in the brain and typically occurs in middle age and beyond. Deep brain stimulation (DBS) is considered when symptoms of Parkinson's disease, such as tremors, slowed movements, and musc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Those aged 40-85
* Those with an ASA score of I-II-III
* Those with a body mass index (BMI) between 18-30
Exclusion Criteria:
* Those under 40 and over 85
* Those with an ASA score of IV or higher
* Those with a BMI of under 18 and over 30
Contacts